Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04243031

QuantiFERON Access Clinical Performance Study Protocol

A Non-interventional, Prospective Clinical Performance Study of the QuantiFERON Access Kit to Demonstrate Clinical Accuracy Compared to a CE-marked In-Vitro Diagnostic Medical Device, in Participants With Varying Risk Factors for TB Infection and Disease.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
QIAGEN Gaithersburg, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Approximately 225 samples, obtained from participants with varying risk factors for TB infection and disease, will be tested using the QFT Access Kit and the comparator device QFT-Plus.

Conditions

Interventions

TypeNameDescription
DEVICEQFT AccessMeasure of Interferon Gamma

Timeline

Start date
2020-04-01
Primary completion
2020-08-01
Completion
2020-11-01
First posted
2020-01-27
Last updated
2020-09-16

Source: ClinicalTrials.gov record NCT04243031. Inclusion in this directory is not an endorsement.